The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Glofitamab monotherapy retreatment in patients with heavily pre-treated relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL): Results from a phase I/II study.
 
Nancy L. Bartlett
Consulting or Advisory Role - Foresight Diagnostics; Genmab/AbbVie (Inst); Kite, a Gilead company; Roche/Genentech
Research Funding - ADC Therapeutics (Inst); Autolus (Inst); Bristol-Myers Squibb/Celgene; Forty Seven (Inst); Janssen (Inst); Kite, a Gilead company; Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Michael Dickinson
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Janssen; MSD; Novartis; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Genmab; Gilead Sciences; Janssen; Novartis; Roche (I)
Research Funding - Abbvie (Inst); Celgene (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche
 
Martin Hutchings
Consulting or Advisory Role - Abbvie; Genmab; Janssen; Roche; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Genmab (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Carmelo Carlo-Stella
Honoraria - ADC Therapeutics; AstraZeneca; Celgene/Bristol-Myers Squibb; Gilead Sciences; Incyte; Janssen Oncology; Merck Sharp & Dohme; Novartis; Roche; SOBI; Takeda
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Celgene/Bristol-Myers Squibb; Janssen Oncology; Karyopharm Therapeutics; Novartis; Roche; Sanofi; Scenic Biotech; SOBI
Research Funding - ADC Therapeutics; Roche (Inst); Sanofi
Travel, Accommodations, Expenses - Janssen Oncology; Roche; Takeda
Other Relationship - Roche
 
Shang-Ju Wu
Honoraria - AstraZeneca; Janssen; MSD; Roche
Consulting or Advisory Role - MSD
Research Funding - AstraZeneca
 
Sirpa Leppä
Honoraria - Gilead Sciences; Incyte; Novartis
Consulting or Advisory Role - BeiGene; Gilead Sciences; Incyte; Novartis; Orion Clinical; Pfizer; Roche; SOBI
Research Funding - Bayer (Inst); Celgene (Inst); Genmab (Inst); Hutchison MediPharma (Inst); Novartis (Inst); Roche (Inst)
 
Marek Trneny
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche; SOBI; Swixx BioPharma; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Autolus; Bristol-Myers Squibb; Caribou Biosciences; Genmab; Gilead Sciences; Incyte; Janssen; MorphoSys; Novartis; Roche; SOBI; Takeda
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Gilead Sciences; janssen; Roche; SOBI; Takeda
 
Paolo Corradini
Honoraria - Abbvie; ADC Therapeutics; Amgen; BeiGene; Celgene; Daiichi Sankyo; GlaxoSmithKline; Incyte; Janssen; Kite/Gilead; Kyowa Kirin; Lilly; Nerviano Medical Sciences; Novartis; Pfizer; Roche; Sanofi; SOBI; Takeda
Travel, Accommodations, Expenses - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Kite/Gilead; Novartis; Roche; Takeda
 
Fritz Offner
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Novartis; Roche
 
Estefania Mulvihill
Employment - Roche; Roche (I)
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Roche
 
Alessia Bottos
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Saibah Chohan
Employment - Roche
 
Pauline Baumlin
No Relationships to Disclose
 
James Relf
Employment - Roche
Stock and Other Ownership Interests - F-Star Biotechnology; Roche
 
Linda Lundberg
Employment - Roche; Roche (I)
Stock and Other Ownership Interests - Roche; Roche (Inst)
Patents, Royalties, Other Intellectual Property - Roche; Roche (I)
 
Emmanuel Bachy
Honoraria - Amgen; Gilead Sciences; Incyte; Janssen-Cilag; Novartis; Roche; Takeda
Consulting or Advisory Role - Gilead Sciences; Incyte; Novartis; Novartis; Roche; Takeda
Research Funding - Amgen Foundation (Inst); Bristol Myers Squibb Foundation (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Incyte; Janssen-Cilag; Roche